Proof of Mechanism Study to Evaluate Binding of Alfa-synuclein
NCT05274568
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Multisystem Atrophy
Healthy Volunteer
Interventions
DRUG:
[18F]UCB-2897
Sponsor
Invicro